From 8 to 11 June, the European Hematology Association (EHA) celebrated in Frankfurt, Germany, their Annual Congress, in which researchers, physicians and partners from all across Europe were invited to meet, share knowledge and discuss the latests advances in hematology. During this 2023 edition, new members of the different EHA’s Committees have been elected. Among them, Dr. Marcus Buschbeck, group leader at the Josep Carreras Leukaemia Research Institute, has been appointed as member of the EHA’s Research Committee (RC).
The EHA’s Research Committee is an important committee inside the EHA’s structure, which serves as an advisory body to the EHA Board and works closely with the EHA Office and other EHA Committees. It coordinates, integrates and promotes research activities across all EHA initiatives, defines their plan and budget and informs EHA Board on their progession and outcomes. EHA-RC is composed by 14 members, all well-renowned hematology experts from different European countries. Reappointments are done every 3 years maximum.
The EHA’s committees are made up by experienced and accomplished researchers and physicians in the hematology field. Together with Dr. Marcus Buschbeck, other researchers from the Josep Carreras Institute are also part of these Committees. Dr. Josep Maria Ribera, group leader of the Acute Lymphoblastic Leukemia group, is councilor of the EHA Board. Dr. Tomàs Navarro, group leader of the Lymphoid neoplasms group, chairs the Curriculum-Exam Committee and is part of the Education Committee and the EHA Campus Working Group Committee. This year 2023, Dr. Carol Moreno, group leader of the Chronic lymphocytic leukemia group, terminated her mandate as member of the EHA Board.
The European Hematology Association is the largest European organization of hematology medical professionals and researchers, with more than 5000 members. EHA supports the research and career development of its members and advocates for the harmonization of hematology education.